24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate

PHASE2CompletedINTERVENTIONAL
Enrollment

359

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Rheumatoid Arthritis
Interventions
DRUG

VX-509

50 mg oral tablet

DRUG

VX-509 matching placebo

0 mg oral tablet

Trial Locations (94)

1023

Vertex Investigational Site, Budapest

1036

Vertex Investigational Site, Budapest

1233

Vertex Investigational Site, Sofia

1784

Vertex Investigational Site, Sofia

3800

Vertex Investigational Site, Szikszó

4002

Vertex Investigational Site, Plovdiv

4103

Vertex Investigational Site, Leipzig

5000

Vertex Investigational Site, Veliko Tarnovo

5801

Vertex Investigational Site, Poprad

6500

Vertex Investigational Site, Baja

10117

Vertex Investigational Site, Tallinn

10128

Vertex Investigational Site, Tallinn

11000

Vertex Investigational Site, Belgrade

11312

Vertex Investigational Site, Tallinn

13419

Vertex Investigational Site, Tallinn

18205

Vertex Investigational Site, Niška Banja

21000

Vertex Investigational Site, Novi Sad

39261

Vertex Investigational Site, Zerbst

50924

Vertex Investigational Site, Cologne

84104

Vertex Investigational Site, Bratislava

97080

Vertex Investigational Site, Würzburg

97901

Vertex Investigational Site, Rimavská Sobota

190068

Vertex Investigational Site, Saint Petersburg

191186

Vertex Investigational Site, Saint Petersburg

Unknown

Vertex Investigational Site, Birmingham

Vertex Investigational Site, Huntsville

Vertex Investigational Site, Long Beach

Vertex Investigational Site, Tustin

Vertex Investigational Site, Boca Raton

Vertex Investigational Site, Daytona Beach

Vertex Investigational Site, New Port Richey

Vertex Investigational Site, North Miami Beach

Vertex Investigational Site, Ocala

Vertex Investigational Site, Tampa

Vertex Investigational Site, Springfield

Vertex Investigational Site, Wichita

Vertex Investigational Site, Kalamazoo

Vertex Investigational Site, St Louis

Vertex Investigational Site, Omaha

Vertex Investigational Site, Las Vegas

Vertex Investigational Site, Clifton

Vertex Investigational Site, Freehold

Vertex Investigational Site, Brooklyn

Vertex Investigational Site, Charlotte

Vertex Investigational Site, Durham

Vertex Investigational Site, Hickory

Vertex Investigational Site, Oklahoma City

Vertex Investigational Site, Bethlehem

Vertex Investigational Site, Duncansville

Vertex Investigational Site, Jackson

Vertex Investigational Site, Austin

Vertex Investigational Site, Houston

Vertex Investigational Site, Mesquite

Vertex Investigational Site, San Antonio

Vertex Investigational Site, Clarksburg

Vertex Investigational Site, Santa Fe

Vertex Investigational Site, Sevlievo

Vertex Investigational Site, Mladá Boleslav

Vertex Investigational Site, Ostrava - Trebovice

Vertex Investigational Site, Chihuahua City

Vertex Investigational Site, Cuauhtémoc

Vertex Investigational Site, San Luis Potos

Vertex Investigational Site, San Miguel Chapultepec

Vertex Investigational Site, Brăila

Vertex Investigational Site, Judetul Galati

Vertex Investigational Site, Kemerovo

Vertex Investigational Site, Moscow

Vertex Investigational Site, Ryazan

Vertex Investigational Site, Yaroslavl

Vertex Investigational Site, Dunajská Streda

Vertex Investigational Site, Donetsk

Vertex Investigational Site, Kharkiv

Vertex Investigational Site, Lviv

Vertex Investigational Site, Odesa

Vertex Investigational Site, Vinnytsia

C1121ABE

Vertex Investigational Site, Buenos Aires

C1425EKG

Vertex Investigational Site, Buenos Aires

C1426AAL

Vertex Investigational Site, Buenos Aires

638 00

Vertex Investigational Site, Brno

792 01

Vertex Investigational Site, Bruntál

760 01

Vertex Investigational Site, Prague

Vertex Investigational Site, Zlín

15-879

Vertex Investigational Site, Bialystok

82-300

Vertex Investigational Site, Elblag

30-510

Vertex Investigational Site, Krakow

20-607

Vertex Investigational Site, Lublin

60-218

Vertex Investigational Site, Poznan

60-539

Vertex Investigational Site, Poznan

87-100

Vertex Investigational Site, Torun

00-029

Vertex Investigational Site, Warsaw

02-118

Vertex Investigational Site, Warsaw

04-141

Vertex Investigational Site, Warsaw

010976

Vertex Investigational Site, Bucharest

011198

Vertex Investigational Site, Bucharest

All Listed Sponsors
lead

Vertex Pharmaceuticals Incorporated

INDUSTRY

NCT01590459 - 24-week Study With Open Label Extension of VX-509, an Oral JAK3 Inhibitor, in Subjects Taking Methotrexate | Biotech Hunter | Biotech Hunter